Market News & Trends
INNERCAP Granted Patent for Multi-Phase, Multi-Compartment Capsular Delivery Apparatus
INNERCAP Technologies, Inc., a combination drug delivery system company, recently announced the grant of US Patent No. 8,361,497 B2 titled Multi-Phase, Multi-Compartment Capsular Delivery Apparatus.…
PolyTherics Receives Milestone Payment From Celtic Pharma
PolyTherics Limited recently announced it has received an undisclosed milestone payment from Celtic Pharma Holdings, triggered by further progress on their haematology alliance to produce…
Accelovance Expansion Continues With CRO Acquisition
Accelovance, Inc. recently announced the acquisition of Radiant Development, the CRO division of Radiant Research. This is the latest development in an expansion strategy by…
3/6/2013
Capsugel Announces Major Acquisition Capsugel recently announced it has acquired Encap Drug Delivery. Based in Scotland, Encap's focus on liquid and semi-solid encapsulation-based product development, and…
Althea Technologies & Profectus BioSciences Sign Manufacturing Agreement
Althea Technologies, Inc. and Profectus BioSciences Inc. recently announced the signing of a manufacturing supply agreement for plasmid DNA production. Under the agreement, Althea…
BioAlliance Pharma Signs Collaborative Agreement With Vaccine Leader
BioAlliance Pharma SA recently announced a collaboration agreement with one of the world-leading vaccine companies to develop a vaccine application of its Lauriad mucoadhesive…
Capsugel Announces Major Acquisition
Capsugel recently announced it has acquired Encap Drug Delivery. Based in Scotland, Encap's focus on liquid and semi-solid encapsulation-based product development, and clinical and…
Kala Pharmaceuticals Secures $11.5 Million
Kala Pharmaceuticals, Inc. recently announced today that it has secured $11.5 million in Series A equity financing through new and existing investors. New and…
Novozymes Biopharma's rAlbumin Approved in Japan
Novozymes Biopharma has recently announced that one of its leading customers has achieved approval of a medical device in Japan using Recombumin Alpha -…
West Announces Commercial Introduction of Novel Intradermal Adapter
West Pharmaceutical Services, Inc. recently announced the commercial introduction of its ID Adapter. West acquired a license to the technology in 2010 and has completed…
Dow Chemical & Cambrex Collaborate to Manufacture Drug Solubility Solution
Cambrex and The Dow Chemical Company recently executed an agreement for Cambrex to contract manufacture Dow Hydroxypropyl Methylcellulose Acetate Succinate (HPMCAS) for Drug Solubility…
ProBioGen Signs Major Technology Deal for Therapeutic Antibody Platform
Another global pharma company has licensed ProBioGen's GlymaxX ADCC-enhancement technology. The license covers the modification of the pharma's antibody production platform for the generation…
Quinten Identifies Synergistic Markers; Predicts Favorable Response to TNBC Treatment
Quinten recently announced the identification of two discriminating biological marker candidates that are indicative of a favorable response to treatment in women suffering from triple-negative…
2/27/2012
BASF & Bend Research Sign Bioavailability Agreement BASF SE and Bend Research Inc. have signed an agreement to jointly evaluate and develop novel excipients to…
BASF & Bend Research Sign Bioavailability Agreement
BASF SE and Bend Research Inc. have signed an agreement to jointly evaluate and develop novel excipients to enhance the solubility and bioavailability of…
BioCellChallenge Launches First Universal Delivery System for Transporting Antibodies Into Live Cells
BioCellChallenge SAS recently announced the launch of a new delivery system, ImmunoCellin, which is designed to transport antibodies into live cells even in the presence…
Capsugel Launches New Dosage Form Solutions Business Unit
Capsugel recently announced the launch of its Dosage Form Solutions (DFS) business unit to address growing customer demand for innovative product development and commercial…
2/20/2013
Argos Therapeutics Announces Updated Phase II Data Argos Therapeutics Inc. recently announced updated results from its Phase II study of AGS-003, its most advanced product…
93% Shares of OctoPlus Acquired
Dr Reddy's Laboratories (DRL), which is in the process of acquiring Netherlands-based speciality pharmaceutical company OctoPlus NV for about 27.4 million euro, has so…
Argos Therapeutics Announces Updated Phase II Data
Argos Therapeutics Inc. recently announced updated results from its Phase II study of AGS-003, its most advanced product candidate for the treatment of metastatic…
